Research Overview

Research Overview

At the Cannabis Science Research Foundation, we understand that evidence-based research is paramount to creating a standard for safe and effective cannabinoid medicine. There are many therapeutic applications of cannabinoids, with countless individuals reporting decreases in their symptoms and increases in their overall quality of life. The medical community is in need of more research in this area, and the Cannabis Science Research Foundation makes this possible.

Because of the many ailments that phytocannabinoids can treat, we take a holistic approach to our research. We are the driving force behind education, better treatments, and exciting new therapies. Our research is conducted in the lab, but also in direct contact with patients, who are the true examples of what cannabinoid medicine can do. Every improvement made in our laboratory setting impacts the next level of cannabinoid research and advancement in therapies. We gain insight into cannabinoid medicine through the following pathways:

  • Preclinical Research
  • Clinical Trials
  • Laboratory Testing
  • Translational Research
  • Medicine Formulations

Not only is our research conducted in the traditional avenues listed above, but we also strive to take a comprehensive approach through our specialized programs. We provide support for patients, an online community, and advocacy at the government level.

The Cannabis Science Research Foundation is committed to patients and the desire to rid the world of the many ailments that afflict humans today through safe and effective means.


Disease-Specific Focus Areas

The proof that cannabinoids can treat these illnesses is in the science, which is explored from various research angles by the Foundation. Phytoannabinoids are being studied more and more, but the Cannabis Science Research Foundation’s state of the art research will benefit the research community in tremendous ways. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that phtyocannabinoids are a dangerous, addictive drug with no medical value is scientifically absurd. The Foundation works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products.

Our goal, simply put, is to prove that phytocannabinoids can treat a variety of illnesses safely and effectively.

There are over 20 ailments the Cannabis Science Research Foundation has identified that respond to cannabinoid-based medication:

  • AIDS / HIV
  • Alzheimer's
  • Asthma
  • Arthritis
  • Autoimmune Disease
  • Brain Trauma (Closed Head Injury)
  • Cancer
  • Chronic Pain or Pain Management
  • Crohn's (IBD)
  • Diabetes
  • Digestive Illnesses
  • Gastro Intestinal Reflux Disease (GERD)
  • Glaucoma
  • High Blood Pressure
  • Influenza
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
  • Multiple Sclerosis (MS)
  • Neurobehavioral Disorders
  • Post Traumatic Stress Syndrome (PTSD)
  • Tourette Syndrome

It is necessary for us to conduct more research about how phytocannabinoids influence these illnesses through the efforts of the Cannabis Science Research Foundation.